Ann: Changes to Board of Directors-MNQ.AX, page-2

The New Board has a wealth of credentials and networking to take this through to higher highs.

Note in particular our new chairman and his venture capital connections.  Expect some great buying on-market for those that could not get any placement stock.

Also take note of prior directorships with Cochlear and Resmed.  (COH = $8 Billion MC, RMD = $11 Billion MC)

In my opinion, with such board backing, Epat is primed to soar.